Olmesartan Medoxomil Drug Combination Amlodipine Besylate

A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION.

Also Known As:

Amlodipine Besylate, Olmesartan Medoxomil Drug Combination; Amlodipine Besylate, Olmesartan Medoxomil; Amlodipine Besylate-Olmesartan Medoxomil; Amlodipine Besylate-Olmesartan Medoxomil Drug Combination; Azor; Amlodipine Besylate Olmesartan Medoxomil; Amlodipine Besylate Olmesartan Medoxomil Drug Combination; Besylate-Olmesartan Medoxomil, Amlodipine; Medoxomil, Amlodipine Besylate-Olmesartan

Networked: 7 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1.	Cerón-Carrasco, José P: 1 article (01/2021)
2.	Jacquemin, Denis: 1 article (01/2021)
3.	Fei, Junjie: 1 article (01/2019)
4.	Jiang, Wen-Li: 1 article (01/2019)
5.	Li, Chun-Yan: 1 article (01/2019)
6.	Li, Yongfei: 1 article (01/2019)
7.	Tian, Yang: 1 article (01/2019)
8.	Zhou, Dong-Ye: 1 article (01/2019)
9.	Ahmad, Mushtaq: 1 article (09/2013)
10.	Ferdinand, Keith C: 1 article (09/2013)

Related Diseases

1.	Hypertension (High Blood Pressure) 08/01/2010 - "Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study."
2.	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/01/2013 - "We evaluated the efficacy of amlodipine and olmesartan (A/O; Azor) versus losartan and hydrochlorothiazide (L/H; Hyzaar), on changes in serum and urine biomarkers of inflammation and oxidation, neutrophil reactive oxygen species generation, and changes in systolic blood pressure (BP), diastolic BP, and heart rate as measured with 24 hours ambulatory BP monitoring in a high-risk, hypertensive African-American population with the metabolic syndrome. "
3.	Inflammation (Inflammations) 09/01/2013 - "We evaluated the efficacy of amlodipine and olmesartan (A/O; Azor) versus losartan and hydrochlorothiazide (L/H; Hyzaar), on changes in serum and urine biomarkers of inflammation and oxidation, neutrophil reactive oxygen species generation, and changes in systolic blood pressure (BP), diastolic BP, and heart rate as measured with 24 hours ambulatory BP monitoring in a high-risk, hypertensive African-American population with the metabolic syndrome. "
4.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/01/2021 - "However, the action of bacterial core enzymes such as azoreductases (AzoR) might also help to deliver prodrugs that become active when they reach the colonic region, a mechanism with potential applications for the treatment of inflammatory bowel disease (IBD) and colorectal cancer. "
5.	Colorectal Neoplasms (Colorectal Cancer) 01/01/2021 - "However, the action of bacterial core enzymes such as azoreductases (AzoR) might also help to deliver prodrugs that become active when they reach the colonic region, a mechanism with potential applications for the treatment of inflammatory bowel disease (IBD) and colorectal cancer. "

Related Drugs and Biologics

1.	Amlodipine (Norvasc)
2.	Olmesartan Medoxomil (Votum)
3.	Hydrochlorothiazide (Esidrix)
4.	Losartan (Cozaar)
5.	Reactive Oxygen Species (Oxygen Radicals)
6.	Biomarkers (Surrogate Marker)
7.	losartan drug combination hydrochlorothiazide
8.	olmesartan
9.	Dexlansoprazole
10.	Ritonavir (Norvir)

Related Therapies and Procedures

1.	Stents